Blood Clot News and Research

RSS

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

Diesel exhaust fumes increase clot formation and blood platelet activity

Increased roadway pollution produced by diesel fuel in vehicles is leading to a cascade of conditions that could result in heart attack or stroke, researchers suggested in the report of a small study presented at the American Heart Association's Scientific Sessions 2007.

6 Nov 2007

Getting to hospital quickly once heart attack symptoms appear provides best chance of receiving right treatment

If you go to the hospital within one to two hours of the onset of symptoms of a heart attack, your chances of getting proper treatment are nearly 70 percent greater than those who wait 11 to 12 hours before seeking treatment, according to results presented at the American Heart Association's Scientific Sessions 2007 in Orlando, Fla.

6 Nov 2007

New risk factor for heart attack patients identified

6 Nov 2007

64-slice CT scans a good test for clogged arteries

A study by an international team of cardiac imaging specialists, led by researchers at Johns Hopkins, concludes that sophisticated computed tomography (CT) scans of the heart and its surrounding arteries are almost as reliable and accurate as more invasive procedures to check for blockages.

6 Nov 2007

New review of catheterization after heart attack

In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn't justified, say researchers from Duke University Medical Center.

6 Nov 2007

Bayer Pharmaceuticals agrees to a marketing suspension of Trasylol

The U.S. Food and Drug Administration (FDA) has announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

5 Nov 2007

Big question over new blood-clot buster drug Prasugrel

New research has revealed that the drug Prasugrel produced by drug company Eli Lilly increases the risk of serious bleeding when compared to the standard therapy.

5 Nov 2007

Treat all patients with rare lung disease to prevent stroke, say doctors

Treatment should be offered to all people with a particular rare lung condition, regardless of whether or not they show symptoms of it, say researchers and doctors behind a new study published today.

5 Nov 2007

Medical causes of iatrogenic renal disorders

Nephrologists and other health care providers need to be aware of certain medications and diagnostic test preparations that, in some patients, can cause damage to the kidneys, according to a special clinical update being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.

5 Nov 2007

MRIs reveal 13% of healthy adults have a brain abnormality

A Dutch study has revealed that as many as 13% of healthy adults may have some type of undiagnosed abnormality in the brain.

4 Nov 2007

Antibody might help starve cancerous tumors

An antibody might offer a safe and effective complement to anti-cancer therapies designed to starve malignant tumors by pruning the blood vessels that feed them, researchers report in the November 2 issue of the journal Cell, a publication of Cell Press.

2 Nov 2007

New studies add weight to link between pre-eclampsia and heart disease

Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.

2 Nov 2007

Review of aspirin therapy

Aspirin, long known to relieve fevers, aches and pain, has served an increasingly bigger role in health care in recent years.

2 Nov 2007

FDA issues communication on ongoing safety review of Aprotinin injection

Last week, FDA was notified that a Canadian research group stopped a study on Trasylol because the drug appeared to increase the risk for death compared to the other antifibrinolytic drugs used in the study. Antifibrinolytic drugs help slow the breakdown of blood clots and subsequent excessive bleeding.

28 Oct 2007

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

24 Oct 2007

Low-dose aspirin for in vitro fertilisation

Although it is inexpensive, easy to obtain and poses little health risk, women undergoing in vitro fertilization (IVF) cannot rely upon aspirin to help them become pregnant, according to a systematic review of nine studies.

23 Oct 2007

High-risk individuals less likely to follow through on HIV testing plans

One-fourth of individuals at high risk for contracting HIV report planning to be tested for the virus in the next year, but fewer appear to follow through on that intention than individuals who are at lower risk, according to a report in the October 22 issue of Archives of Internal Medicine.

22 Oct 2007